EGFR and esophageal cancer: Concurrently, EGFR overexpression has been observed in approximately 30-70% of esophageal cancers (22), and EGFR-TKIs have been demonstrated to disrupt cell proliferation and enhance the radiosensitivity of cancer cells (23, 24).